Prudential Financial’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,570
Closed -$854K 2520
2025
Q4
$854K Sell
6,570
-6,980
-52% -$958K ﹤0.01% 1653
2025
Q3
$1.46M Sell
13,550
-14,570
-52% -$1.59M ﹤0.01% 1503
2025
Q2
$2.6M Sell
28,120
-44,738
-61% -$3.51M ﹤0.01% 1254
2025
Q1
$6.45M Sell
72,858
-30,417
-29% -$2.64M 0.01% 739
2024
Q4
$7.94M Buy
+103,275
New +$7.21M 0.01% 698
2024
Q1
Sell
-13,200
Closed -$36.3K 2767
2023
Q4
$36.3K Buy
+13,200
New +$30.7K ﹤0.01% 2580

Other funds holding WGS

Prudential Financial's WGS Position: Q1 2026 in Review

Prudential Financial sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 6,570 shares — an estimated $854K sold.

Prudential Financial first reported a position in WGS in Q4 2023 and held it in 6 quarters. The position peaked at $7.94M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Prudential Financial reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Prudential Financial sold 6,570 GeneDx Holdings shares in Q1 2026, an estimated $854K.
  • Prudential Financial first reported a position in GeneDx Holdings in Q4 2023 and held it in 6 quarters.
  • Prudential Financial's GeneDx Holdings position peaked at $7.94M in Q4 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.